Tonix Pharmaceuticals Holding Corp.: Revision history

20 August 2022

• curprev 21:2821:28, 20 August 2022 95.149.241.133 talk 1,600 bytes +11 No edit summary undo

14 August 2022

• curprev 08:5008:50, 14 August 2022 109.180.50.163 talk 1,589 bytes +15 No edit summary undo

31 July 2022

• curprev 11:5111:51, 31 July 2022 >Chris 1,574 bytes +1,574 Created page with "Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and licensing therapeutics and diagnostics to treat and prevent human disease and alleviate suffering. Its portfolio includes immunology, rare disease, infectious disease, and central nervous system (CNS) product candidates. The company's immunology portfolio includes biologics to address organ transplant rejection, autoimmunity, and cancer, inc..."